In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Revvity's current price exceeds the PERT-weighted fair value by 30%, suggesting overvaluation with high downside risk (75%). Profitability and efficiency scores are low, while leverage is high, indicating financial strain. Monte Carlo analysis shows wide valuation dispersion ($51.85–$406.98) with elevated volatility, reflecting substantial investment risk.